This comprehensive book, Coagulation in Cancer, edited by David Green and Hau C. Kwaan, is a much-needed compilation of recent studies and current concepts of the subject. The 32 contributors have in this concise book covered the subject in 18 dedicated chapters. The book has a complete index.
This book is subdivided into 3 parts: Part I: Alterations in Hemostasis Due to Cancer; Part II: Thrombotic Disorders Associated with Cancer; and Part III: Bleeding Disorders Associated with Cancer. Of particular interest are the cellular mechanisms involved in thrombosis and fibrinolysis as related to malignant cells, the participation of growth factors in enhancement of tumor growth and medistatic disease, and the effect of anticoagulants on survival in cancer patients. Many will appreciate the chapters emphasizing the high probability of thromboembolism and bleeding and myeloproliferative disorders. There is an excellent chapter on coagulation and bleeding in children with cancer. Clinicians and research investigators alike will appreciate the large number of pertinent references to be found in the bibliographies of these articles. These same individuals should find the relatively low price and the concise discussions of the subject to be important considerations. This third edition of the book entitled New Therapeutic Agents in Thrombosis and Thrombolysis is indeed an extensively updated review of current knowledge of the blood coagulation system along with dedicated chapters on every aspect of clinical cardiovascular thrombosis. These chapters include anticoagulation in pregnancy and heparin-induced thrombocytopenia, as well as anticoagulants and thrombolytic agents in deep vein thrombosis, pulmonary embolism, acute coronary syndrome, and stroke. Emphasis is placed on molecular biologic mechanisms, pharmacogenomics, proteomics, and up-to-date information on the role of platelets in cardiovascular thrombosis. Chapters on newer agents such as oral factor Xa inhibitors, factor IXa inhibitors, and newer thrombolytics provide the reader with details of the latest information on antithrombotic drugs. This volume is likely to be extremely valuable to those in the cardiovascular field as well as those in hematology and the basic sciences such as pharmacology and clinical pathology.
